Mycoplasmal lipopeptide MALP-2 induces the chemoattractant proteins macrophage inflammatory protein 1α (MIP-1α, monocyte chemoattractant protein 1, and MIP-2 and promotes leukocyte infiltration in mice

Infection and Immunity

Volumn 67, Issue 7, 1999, Pages 3390-3398

  Deiters, Ursula ^a   Mühlradt, Peter F ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; LIPOPEPTIDE; MACROPHAGE ACTIVATING FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; LEUKOCYTE ACTIVATION; MACROPHAGE; MONOCYTE; MOUSE; MYCOPLASMA HOMINIS; NONHUMAN; PERITONEUM LAVAGE; PRIORITY JOURNAL;

EID: 0344416987     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.7.3390-3398.1999     Document Type: Article

References (48)

1. Alam, R., D. Kumar, D. Anderson-Walters, and P. A. Forsythe. 1994. Macrophage inflammatory protein-1α and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J. Immunol. 152:1298-1303.
2. Appelberg, R. 1992. Interferon-gamma (IFN-gamma) and macrophage inflammatory proteins (MIP)-1 and -2 are involved in the regulation of the T cell-dependent chronic peritoneal neutrophilia of mice infected with mycobacteria. Clin. Exp. Immunol. 89:269-273.
3. Baseman, J. B., and J. G. Tully. 1997. Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg. Infect. Dis. 3:21-32.
4. Calcutt, M. J., M. F. Kim, A. B. Karpas, P. F. Mühlradt, and K. S. Wise. 1999. Differential post-translational processing confers intraspecies variation of a major lipopeptide (MALP-2) of Mycoplasma fermentans. Infect. Immun. 67:760-771.
5. Collins, P. D., P. J. Jose, and T. J. Williams. 1991. The sequential generation of neutrophil chemoattractant proteins in acute inflammation in the rabbit in vivo. J. Immunol. 146:677-684.
6. Dagnall, G. J. R. 1993. Experimental infection of the conjunctival sac of lambs with Mycoplasma conjunctivae. Br. Vet. J. 149:429-435.
7. Deiters, U., G. Sonntag, O. Götze, and P. F. Mühlradt. Unpublished results.
8. Devine, D. V., K. Wong, K. Serrano, A. Chonn, and P. R. Cullis. 1994. Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta 1191:43-51.
9. DiPietro, L. A., M. Burdick, Q. E. Low, S. L. Kunkel, and R. M. Strieter. 1998. MIP-1α as a critical macrophage chemoattractant in murine wound repair. J. Clin. Investig. 101:1693-1698.
10. Doherty, N. S., R. J. Griffiths, J. P. Hakkinen, D. N. Scampoli, and A. J. Milici. 1995. Post-capillary venules in the "milky spots" of the greater omentum are the major site of plasma protein and leukocyte extravasation in rodent models of peritonitis. Inflamm. Res. 44:169-177.
11. Driscoll, K. E. 1994. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp. Lung Res. 20:473-490.
12. Ezekowitz, R. A. B., J. Austyn, P. D. Stahl, and S. Gordon. 1981. Surface properties of Bacillus Calmette-Guérin-activated mouse macrophages. J. Exp. Med. 154:60-76.
13. Fahey, T. J., III, K. J. Tracey, P. Tekamp-Olson, L. S. Cousens, W. G. Jones, G. T. Shires, A. Cerami, and B. Sherry. 1992. Macrophage inflammatory protein 1 modulates macrophage function. J. Immunol. 148:2764-2769.
14. Freudenberg, M. A., and C. Galanos. 1991. Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun. 59:2110-2115.
15. Griswold, D. E., E. F. Webb, and L. M. Hillegass. 1991. Induction of plasma exudation and inflammatory cell infiltration by leukotriene C4 and leukotriene B4 in mouse peritonitis. Inflammation 15:251-258.
16. Hauschildt, S., H. U. Beuscher, G. Jung, W. Bessler, and A. Ulmer. 1994. Intraperitoneal injection of synthetic bacterial lipopeptides does not cause a rise in circulating inflammatory cytokines. FEMS Immunol. Med. Microbiol. 8:77-82.
17. Hechtman, D. H., M. I. Cybulsky, H. J. Fuchs, J. B. Baker, and M. A. Grimbrone Jr. 1991. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J. Immunol. 147: 883-892.
18. Howard, C. J., J. C. Anderson, R. N. Gourlay, and D. Taylor-Robinson. 1975. Production of mastitis in mice with human and bovine ureaplasmas (T-mycoplasmas). J. Med. Microbiol. 8:523-529.
19. Introna, M., R. Bast, C. Tannenbaum, and D. Adams. 1987. The effect of LPS on expression of the early "competence" genes JE and KC in murine peritoneal macrophages. J. Immunol. 138:3891-3896.
20. Issekutz, A. C., and S. Bhimji. 1982. Role for endotoxin in the leukocyte infiltration accompanying Escherichia coli inflammation. Infect. Immun. 36: 558-566.
21. Kalmar, J. R., and T. E. van Dyke. 1994. Effect of bacterial products on neutrophil chemotaxis. Methods Enzymol. 236:58-87.
22. Kennedy, S., and H. J. Ball. 1987. Pathology of experimental Ureaplasma mastitis in ewes. Vet. Pathol. 24:302-307.
23. Lindsey, J. R., and G. H. Cassell. 1973. Experimental Mycoplasma pulmonis infection in pathogen-free mice. Am. J. Pathol. 72:63-90.
24. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
25. Lowry, O. H., N. R. Roberts, K. Y. Leiner, M.-L. Wu, and A. L. Farr. 1954. The quantitative histochemistry of brain. I. Chemical methods. J. Biol. Chem. 207:1-17.
26. Luini, W., S. Sozzani, J. van Damme, and A. Mantovani. 1994. Species-specificity of monocyte chemotactic protein-1 and -3. Cytokine 4:28-31.
27. Maniloff, J. 1983. Evolution of wall-less procaryotes. Annu. Rev. Microbiol. 37:477-499.
28. Mason, M. J., and D. E. van Epps. 1989. In vivo neutrophil emigration in response to interleukin-1 and tumor necrosis factor-alpha. J. Leukocyte Biol. 45:62-68.
29. Matsumoto, M., M. Nishiguchi, S. Kikkawa, H. Nishimura, S. Nagasawa, and T. Seya. 1998. Structural and functional properties of complement-activating protein M161Ag, a Mycoplasma fermentans gene product that induces cytokine production by human monocytes. J. Biol. Chem. 273:12407-12414.
30. Mühlradt, P. F., and M. Frisch. 1994. Purification and partial biochemical characterization of a Mycoplasma fermentans-derived substance that activates macrophages to release nitric oxide, tumor necrosis factor, and interleukin-6. Infect. Immun. 62:3801-3807.
31. Mühlradt, P. F., and U. Schade. 1991. MDHM, a macrophage-stimulatory product of Mycoplasma fermentans, leads to in vitro interleukin-1 (IL-1), IL-6, tumor necrosis factor, and prostaglandin production and is pyrogenic in rabbits. Infect. Immun. 59:3969-3974.
32. Mühlradt, P. F., M. Kieß, H. Meyer, R. Süßmuth, and G. Jung. 1997. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 185:1951-1958.
33. Mühlradt, P. F., M. Kieß, H. Meyer, R. Süßmuth, and G. Jung. 1998. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis. Infect. Immun. 66:4804-4810.
34. Rollins, S., T. Colby, and F. Clayton. 1986. Open lung biopsy in Mycoplasma pneumoniae pneumonia. Arch. Pathol. Lab. Med. 110:34-41.
35. Ross, S. E., J. W. Simecka, G. P. Gambill, J. K. Davis, and G. H. Cassell. 1992. Mycoplasma pulmonis possesses a novel chemoattractant for B lymphocytes. Infect. Immun. 60:669-674.
36. Saukkonen, K., S. Sande, C. Cioffe, S. Wolpe, B. Sherry, A. Cerami, and E. Tuomanen. 1990. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J. Exp. Med. 171:439-448.
37. Sayers, T. J., T. A. Wiltrout, C. A. Bull, A. C. Denn III, A. M. Pilaro, and B. Lokesh. 1988. Effect of cytokines on polymorphonuclear neutrophil infiltration in the mouse. J. Immunol. 141:1670-1677.
38. Taub, D. D. 1996. Chemokine-leukocyte interactions. The vodoo that they do so well. Cytokine Growth Factor Rev. 7:355-376.
39. Taylor-Robinson, D. 1996. Infections due to species of Mycoplasma and Ureaplasma: an update. Clin. Infect. Dis. 23:671-684.
40. Tuffrey, M. A., P. M. Furr, P. Falder, and D. Taylor-Robinson. 1984. The anti-Chlamydial effect of experimental Mycoplasma pulmonis infection in the murine genital tract. J. Med. Microbiol. 17:357-362.
41. Tully, J. G. 1993. Current status of the mollicutes flora of humans. Clin. Infect. Dis. 17(Suppl. 1):S2-S9.
42. Utsugi, T., C. P. N. Dinney, J. J. Killion, and I. J. Fidler. 1991. In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362. Cancer Immunol. Immunother. 33:375-381.
43. van Rooijen, N., R. van Nieuwmegen, and E. W. A. Kamperdijk. 1985. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. Ultrastructural aspects of elimination of marginal zone macrophages. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 49:375-383.
44. Vink, A., P. G. Coulie, P. Wauters, R. P. Nordan, and J. van Snick. 1988. B cell growth and differentiation activity of interleukin-HP1 and related murine plasmacytoma growth factors. Synergy with interleukin 1. Eur. J. Immunol. 18:607-612.
45. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. Methods Carbohydr. Chem. 5:83-91.
46. Wolpe, S. D., B. Sherry, D. Juers, G. Davatelis, R. W. Yurt, and A. Cerami. 1989. Identification and characterization of macrophage inflammatory protein 2. Proc. Natl. Acad. Sci. USA 86:612-616.
47. Zachariae, C. O. C., A. O. Anderson, H. L. Thomson, E. Appella, A. Mantovani, J. J. Oppenheim, and K. Katsushima. 1990. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J. Exp. Med. 171:2177-2182.
48. Zuckerman, S. H., G. F. Evans, and L. D. Butler. 1991. Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression. Infect. Immun. 59:2774-2780.